Method
Level · gp.fundamentals.debt_to_revenue
Raw value 569.96% · OPTIONAL
· Biological Products, (No Diagnostic Substances)
RESEARCH SNAPSHOTAMGEN INC's latest supported as-filed period reports revenue of $10.1B, 9.5% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
Raw value 569.96% · OPTIONAL
Level · gp.fundamentals.capex_revenue_ratio
Raw value 5.10% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 39.81% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 9.53% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 61.87% · OPTIONAL
Level · gp.fundamentals.operating_margin
Raw value 34.95% · CORE
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +74.3% from the comparable as-filed period.
Debt changed +2.0% from the comparable as-filed period.
Inventory changed -5.5% from the comparable as-filed period.
Net income changed +65.9% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
AMGN · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0000318154-26-000137SEC ↗4Aug 12, 2026Period Aug 7, 20260000318154-26-000135SEC ↗4Aug 10, 2026Period Aug 7, 20260000318154-26-000133SEC ↗4Aug 10, 2026Period Aug 7, 20260000318154-26-000132SEC ↗4Aug 10, 2026Period Aug 7, 20260000318154-26-000131SEC ↗4Aug 7, 2026Period Aug 6, 20260000318154-26-000130SEC ↗4Aug 7, 2026Period Aug 6, 20260000318154-26-000129SEC ↗10-QTransaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 13, 2026Filed Aug 13, 2026 | Khosla RachnaSVP, Business Development | Option ExerciseDirect | 1,252 | $163 | $203,575 | Form 4 ↗ |
| Aug 13, 2026Filed Aug 13, 2026 | Khosla RachnaSVP, Business Development | Open Market SaleDirect | 1,252 | $416 | $521,365 | Form 4 ↗ |
| Aug 13, 2026Filed Aug 13, 2026 | Khosla RachnaSVP, Business Development | Option ExerciseDirect | 1,252 | $0 | $0 | Form 4 ↗ |
| Aug 11, 2026Filed Aug 13, 2026 | Khosla RachnaSVP, Business Development | Open Market SaleDirect | 2,000 | $413 | $825,134 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Level · gp.fundamentals.sbc_revenue_ratio
Raw value 1.64% · OPTIONAL
Operating income changed +32.3% from the comparable as-filed period.
Operating margin moved +6.02 percentage points from the comparable as-filed period.
Revenue changed +9.5% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0000318154-26-000126